TRUPHARMA, FDA Tuesday, March 3, 2020 +0.10 Neutral

FDA Approves METFORMIN HYDROCHLORIDE ORAL SOLUTION — TRUPHARMA, LLC

TRUPHARMA LLC secured U.S. approval for its generic Metformin Hydrochloride Oral Solution, expanding the supply chain for the widely used Type 2 diabetes treatment. The launch is poised to intensify price competition within the oral liquid antidiabetic market.

View original filing at SEC.gov →

AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed